Table 1.
The preoperative clinical characteristics of ULSM group and control group
| ULMS group (N = 45) | Control group (N = 180) | P | |
|---|---|---|---|
| Age, yrs | 47.0 ± 9.7 | 41.2 ± 7.7 | <0.001 |
| Postmenopausal | 9 (20.0) | 9 (5.0) | 0.003 |
| Gravidity | 2.2 ± 1.9 | 1.9 ± 1.4 | 0.169 |
| Parity | 1.1 ± 0.6 | 0.8 ± 0.6 | 0.008 |
| BMI, kg/m2 | 23.0 ± 2.9 | 22.8 ± 3.5 | 0.801 |
| Manifestations | 27 (60.0) | 106 (58.9) | 0.892 |
| Abnormal uterine bleeding | 20 (44.4) | 85 (47.2) | 0.738 |
| Compression symptoms | 4 (8.9) | 23 (12.8) | 0.612 |
| Overall uterine size, cm | 9.6 ± 2.6 | 8.0 ± 2.4 | 0.009 |
| Myoma size, cm | 7.8 ± 2.3 | 6.2 ± 2.5 | <0.001 |
| ≥8 cm | 24 | 32 | <0.001 |
| Solitary presumed myoma | 19 | 72 | 0.786 |
| CA125, IU/L, in 140 cases | 30.0 ± 39.6 | 23.9 ± 17.6 | 0.218 |
| CA199, IU/L, in 72 cases | 9.8 ± 8.9 | 20.2 ± 31.0 | 0.136 |
| Neutrophil, × 109/L | 5.4 ± 3.2 | 3.5 ± 1.2 | <0.001 |
| Lymphocyte, × 109/L | 1.8 ± 0.6 | 2.5 ± 1.2 | 0.669 |
| NLR | 3.3 ± 2.5 | 2.3 ± 1.1 | 0.007 |
| HCT, % | 37.0 ± 5.3 | 37.6 ± 3.8 | 0.446 |
| Platelet, ×109/L | 323.4 ± 112.2 | 272.1 ± 71.4 | 0.005 |
| LDH, U/L | 212.3 ± 57.2 | 169.1 ± 27.0 | <0.001 |
| Initial surgery | <0.001 | ||
| Total hysterectomy | 33 | 57 | |
| Myomectomy | 12 | 123 |
Data was given as mean ± SD or n (%)
ULSM uterine leiomyosarcoma, BMI body mass index, NLR neutrophil-to-lymphocyte ratio, LDH, lactate dehydrogenase, HCT hematocrit